2012 - 2014 the therapeutic resistant mechanisms of head and neck cancer stem cells
Papers (83)：
Woo Hee Lee, Yukinori Takenaka, Kiyohito Hosokawa, Hirotaka Eguchi, Masami Suzuki, Takahito Fukusumi, Motoyuki Suzuki, Hidenori Inohara. Changes in serum lactate dehydrogenase as a prognostic factor in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. Acta oto-laryngologica. 2024. 1-6
Mitsuaki Tatsumi, Hidenori Tanaka, Yukinori Takenaka, Motoyuki Suzuki, Takahito Fukusumi, Hirotaka Eguchi, Tadashi Watabe, Hiroki Kato, Shinichi Yachida, Hidenori Inohara, et al. Association of circulating tumor HPV16DNA levels and quantitative PET parameters in patients with HPV-positive head and neck squamous cell carcinoma. Scientific Reports. 2024. 14. 1
Kiyohito Hosokawa, Yukinori Takenaka, Takashi Sato, Takeshi Tsuda, Hirotaka Eguchi, Masami Suzuki, Koji Kitamura, Takahito Fukusumi, Motoyuki Suzuki, Hidenori Inohara. Small-cell carcinoma in the head and neck region: A propensity score-matched analysis of the effect of surgery. PloS one. 2024. 19. 10. e0312455
Noriyuki Miyamoto, Yukinori Takenaka, Takato Sudo, Hirotaka Eguchi, Hidenori Tanaka, Takahito Fukusumi, Norihiko Takemoto, Motoyuki Suzuki, Hidenori Inohara. Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. Acta oto-laryngologica. 2023. 1-6
Takeshi Tsuda, Takahito Fukusumi, Miyu Saito, Atsuto Kuki, Hidenori Inohara. Microscopic Residual Disease After Nasal Squamous Cell Carcinoma Not Visualized on FDG PET-CT: A Case Report. Cureus. 2023. 15. 10. e47451
